Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
HLVX | HilleVax, Inc. | CFO & Chief Business Officer | $11.9M | Apr 28, 2022 | ||
PHAT | Phathom Pharmaceuticals, Inc. | Director | $11.2M | May 23, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|